| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.002 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.087 | 0.002 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.092 | 0.003 |